Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Donegal Bio Ventures, LLC is a venture capital firm located in Nashville, Tennessee, specializing in the life sciences sector. The firm manages a portfolio of five companies and focuses on investments that develop innovative therapies and technologies. Their mission centers on supporting companies that improve patient outcomes and address unmet medical needs.
Donegal Bio Ventures invests in companies that create innovative therapies and technologies within the life sciences. Their primary sectors include ophthalmology, aesthetics, and regenerative medicine, with a focus on addressing unmet medical needs. Typical investments target firms that are developing solutions to improve patient care and outcomes.
Notable companies in Donegal Bio Ventures' portfolio include Eyevance Pharma, which develops therapies for ophthalmic healthcare providers; Dominion Aesthetic Technologies, known for its FDA-cleared EON robotic body contouring platform; Elucid Bio, which focuses on AI applications for cardiovascular diagnostics; IVIVA Medical, working on tissue constructs for end-stage renal disease; and Panacea Life Science, which develops hemp-based products for patients.
Donegal Bio Ventures focuses on companies in the life sciences sector that develop innovative therapies and technologies, particularly in ophthalmology, aesthetics, and regenerative medicine.
The firm currently has a portfolio of five companies, each addressing various unmet medical needs in the healthcare space.
Donegal Bio Ventures primarily invests in North America, targeting firms that align with their investment thesis in the life sciences.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.